MARX Biotech Co (ROCO:7731) Cash-to-Debt : 81.12 (As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is MARX Biotech Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. MARX Biotech Co's cash to debt ratio for the quarter that ended in Dec. 2023 was 81.12.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, MARX Biotech Co could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for MARX Biotech Co's Cash-to-Debt or its related term are showing as below:

ROCO:7731' s Cash-to-Debt Range Over the Past 10 Years
Min: 2 Med: 8.72 Max: 81.12
Current: 81.12

During the past 3 years, MARX Biotech Co's highest Cash to Debt Ratio was 81.12. The lowest was 2.00. And the median was 8.72.

ROCO:7731's Cash-to-Debt is ranked better than
90.34% of 673 companies
in the Healthcare Providers & Services industry
Industry Median: 0.69 vs ROCO:7731: 81.12

MARX Biotech Co Cash-to-Debt Historical Data

The historical data trend for MARX Biotech Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

MARX Biotech Co Cash-to-Debt Chart

MARX Biotech Co Annual Data

Trend

Dec20

Dec21

Dec22

Cash-to-Debt

N/A

7.66

2.00

MARX Biotech Co Quarterly Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial			7.66	N/A	2.00	9.78	81.12

Competitive Comparison of MARX Biotech Co's Cash-to-Debt

For the Pharmaceutical Retailers subindustry, MARX Biotech Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MARX Biotech Co's Cash-to-Debt Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MARX Biotech Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where MARX Biotech Co's Cash-to-Debt falls into.

MARX Biotech Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

MARX Biotech Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	27.732	/	(12.967	+	0.871)
	=	2.00

MARX Biotech Co's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	152.827	/	(1.262	+	0.622)
	=	81.12

MARX Biotech Co (ROCO:7731) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

MARX Biotech Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of MARX Biotech Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

MARX Biotech Co (ROCO:7731) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MARX Biotech Co Ltd (ROCO:7731) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

5th Floor, No. 655, Bannan Road, Zhonghe district, New Taipei, TWN

Website

https://www.marxbiotech.com

MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.

MARX Biotech Co (ROCO:7731) Headlines

No Headlines